PL3490533T3 - Sposób stabilizacji rozmiaru cząstek - Google Patents
Sposób stabilizacji rozmiaru cząstekInfo
- Publication number
- PL3490533T3 PL3490533T3 PL17751294T PL17751294T PL3490533T3 PL 3490533 T3 PL3490533 T3 PL 3490533T3 PL 17751294 T PL17751294 T PL 17751294T PL 17751294 T PL17751294 T PL 17751294T PL 3490533 T3 PL3490533 T3 PL 3490533T3
- Authority
- PL
- Poland
- Prior art keywords
- particle size
- stabilization process
- size stabilization
- particle
- stabilization
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16382374 | 2016-07-29 | ||
EP17751294.4A EP3490533B1 (en) | 2016-07-29 | 2017-07-25 | Particle size stabilization process |
PCT/EP2017/068707 WO2018019803A1 (en) | 2016-07-29 | 2017-07-25 | Particle size stabilization process |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3490533T3 true PL3490533T3 (pl) | 2020-11-02 |
Family
ID=56842772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL17751294T PL3490533T3 (pl) | 2016-07-29 | 2017-07-25 | Sposób stabilizacji rozmiaru cząstek |
Country Status (7)
Country | Link |
---|---|
US (1) | US10888500B2 (pl) |
EP (1) | EP3490533B1 (pl) |
AR (1) | AR109186A1 (pl) |
ES (1) | ES2805434T3 (pl) |
PL (1) | PL3490533T3 (pl) |
PT (1) | PT3490533T (pl) |
WO (1) | WO2018019803A1 (pl) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2956062A (en) | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
GB0409703D0 (en) | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
WO2009007666A1 (en) | 2007-07-10 | 2009-01-15 | Redcliffe Magtronics Ltd | Automatic vehicle guidance protection system |
CA2707594C (en) | 2007-12-13 | 2015-08-18 | Novartis Ag | Process for preparing particulates of crystalline drug substance |
EP2234595B1 (en) | 2007-12-13 | 2012-11-28 | Novartis AG | Process for reducing the tendency of a glycopyyronium salt to aggegate during storage. |
ES2712988T5 (es) | 2013-03-15 | 2022-10-21 | Pearl Therapeutics Inc | Métodos y sistemas para acondicionamiento de materiales cristalinos en partículas |
US9393202B2 (en) * | 2013-04-26 | 2016-07-19 | Chiesi Farmaceutici S.P.A | Particle size reduction of an antimuscarinic compound |
ES2700597T3 (es) | 2014-12-24 | 2019-02-18 | Lesvi Laboratorios Sl | Proceso para la preparación de (3RS) -3 - [(2SR) - (2-ciclopentil-2-hidroxi-2-fenilacetil) oxi] -1,1-dimetilpirrolidinio |
-
2017
- 2017-07-25 PL PL17751294T patent/PL3490533T3/pl unknown
- 2017-07-25 US US16/321,034 patent/US10888500B2/en active Active
- 2017-07-25 PT PT177512944T patent/PT3490533T/pt unknown
- 2017-07-25 EP EP17751294.4A patent/EP3490533B1/en active Active
- 2017-07-25 ES ES17751294T patent/ES2805434T3/es active Active
- 2017-07-25 WO PCT/EP2017/068707 patent/WO2018019803A1/en unknown
- 2017-07-27 AR ARP170102134A patent/AR109186A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
PT3490533T (pt) | 2020-07-21 |
US10888500B2 (en) | 2021-01-12 |
EP3490533A1 (en) | 2019-06-05 |
US20190175451A1 (en) | 2019-06-13 |
WO2018019803A1 (en) | 2018-02-01 |
EP3490533B1 (en) | 2020-05-27 |
AR109186A1 (es) | 2018-11-07 |
ES2805434T3 (es) | 2021-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1249994A1 (zh) | 具有減小的粒度的電子汽化器 | |
IL246989A0 (en) | A controlled process to reduce particle size | |
PL3265271T3 (pl) | Podajnik cząstek | |
GB201609546D0 (en) | Process | |
IL255354B (en) | Stable suspensions of nanomagnetic particles | |
GB201605121D0 (en) | Process | |
GB201615268D0 (en) | Process | |
PL3096866T3 (pl) | Drobnoziarnisty węgiel aktywowany | |
GB201609873D0 (en) | Process | |
GB201615270D0 (en) | Process | |
GB201600290D0 (en) | Process | |
GB201617500D0 (en) | Process | |
GB201602646D0 (en) | Process | |
GB201602584D0 (en) | Process | |
GB201701573D0 (en) | Virus-like particle | |
GB201600456D0 (en) | Process | |
GB201600287D0 (en) | Process | |
GB201617463D0 (en) | Process | |
EP3356472C0 (en) | PARTICLE SURFACE TREATMENT | |
GB201610852D0 (en) | Process | |
PT3548452T (pt) | Partícula de fertilizante | |
GB201411407D0 (en) | Particle beam treatment | |
GB201613014D0 (en) | Process | |
EP3414334C0 (en) | PROCESS | |
GB201610338D0 (en) | Process |